Market Research Logo

Azerbaijan Pharmaceuticals and Healthcare Report Q4 2017

Azerbaijan Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Azerbaijan's pharmaceutical market outlook is dependent on the successful launch of itscompulsory health insurance system. This will considerably reduce the reliance on out-of-pocket payments,increasing medicine affordability and accessibility. Preference for generic and non-prescription medicineswill remain prominent given the low-income nature of the population.

Healthcare Expenditure Projections

Pharmaceuticals: AZN497mn (USD309mn) in 2016 to AZN510mn (USD287mn) in 2017; +2.5% inlocal currency and -7.0% in US dollar terms.

Healthcare: AZN4.21bn (USD2.61bn) in 2016 to AZN4.63bn (USD2.61bn) in 2017; +10.0% in localcurrency and -0.3% in US dollar terms.

Risk/Reward Index

Azerbaijan will remain a highly unattractive market for innovative medicine launches, reflected in its scoreof 30.8 out of 100 in BMI's Innovative Pharmaceuticals Risk Reward Index, ranking it third from bottom inthe Europe region. Weak purchasing power and restricted access to healthcare services will continue toimpede growth of patented drugs while the regulatory environment will pose significant market accessbarriers.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Azerbaijan 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Azerbaijan 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Azerbaijan 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Azerbaijan 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Azerbaijan 2013-2021)
Industry Risk Reward Ratings
Central And Eastern Europe Pharmaceuticals: A Mixture Of Opportunities
Azerbaijan Risk/Reward Index
Reward
Risk
Regulatory Development
Pricing Regime
Table: Pharmaceutical Mark-Ups
Pharmaceutical Advertisement
Market Overview
Healthcare Sector
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Demographic Forecast
Table: Population Headline Indicators (Azerbaijan 1990-2025)
Table: Key Population Ratios (Azerbaijan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Azerbaijan 1990-2025)
Table: Population By Age Group (Azerbaijan 1990-2025)
Table: Population By Age Group % (Azerbaijan 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report